NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan

What the company announced

NeoGenomics' Board announced a succession plan that names Warren Stone, current President and Chief Operating Officer, as Chief Executive Officer and a member of the Board effective January 4, 2027. Tony Zook will remain CEO through January 3, 2027 and assume the role of Executive Chairman effective January 4, 2027. The Board also appointed Michael Kelly as Lead Independent Director effective January 4, 2027. Lynn Tetrault will step down as Chair effective January 4, 2027, will continue to serve as an independent director until the 2027 Annual Meeting of Stockholders, and does not intend to stand for reelection at that meeting. These appointments are described by the company as the result of planned succession and years of deliberate succession planning by the Board.

Sources: S1

Preliminary financial picture provided by the company

NeoGenomics described preliminary, unaudited third quarter results and guidance implications. The company stated it expects to report third quarter total revenue of approximately $209 million, including year-over-year NGS revenue growth of approximately 28%. The press release notes that the company is reiterating its full year total revenue and adjusted EBITDA guidance issued on July 28, 2026, and that further details, including an expected increase to full year total revenue guidance resulting from third quarter performance, will be provided on the third quarter earnings call. The release emphasizes these estimated results are preliminary and unaudited and remain subject to quarter-end close and potential final adjustments.

Sources: S1

Context and issuer statements

All executive appointments, timing, and the company's preliminary financial estimates are presented by NeoGenomics in its press release. The company characterizes the transition as reflecting continuity of strategy and cites Mr. Stone's prior roles at NeoGenomics and his industry experience. The release also contains customary forward-looking statements and a caution that actual results may differ materially from preliminary estimates.

Sources: S1

What remains uncertain

• The reported third quarter revenue and NGS growth figures are preliminary, unaudited, and subject to completion of quarter-end closing procedures and potential final adjustments.
• The leadership transitions are announcement-based and described by the issuer; successful completion on the anticipated timeline and without business disruption is a forward-looking outcome the company identifies as uncertain.
• The company’s statements about expected increases to full year guidance and future performance are forward-looking and subject to the risks listed in its filings and in the press release.
• Independent verification of the preliminary financial figures and of any operational effects of the leadership change is not provided in the press release.